NCT02436603

Brief Summary

The purpose of this project is to examine whether a low cost, group-oriented integrative medicine approach to irritable bowel syndrome improves participant outcomes. The intervention will combine nutrition counseling on the low FODMAP diet (decreased grains and other disaccharides) and mind-body training with follow-up health coaching. These participants will be randomized to either a 4-week group-oriented treatment intervention incorporating a low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diet and mind-body therapies followed by an 8-week health coaching follow-up period or a waitlist control group. At the end of the 12-week study period, waitlist subjects will be offered the four-week nutrition and mind-body intervention. Over the 12-week study period, we will examine and report on the impact of this treatment intervention on IBS symptoms and quality of life in this population. The investigators will collect data on IBS outcomes as well as on depression and stress.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

April 28, 2015

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 7, 2015

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2017

Completed
Last Updated

February 14, 2018

Status Verified

February 1, 2018

Enrollment Period

2.2 years

First QC Date

April 28, 2015

Last Update Submit

February 12, 2018

Conditions

Keywords

Irritable Bowel SyndromeIBSMind-Body TrainingIntegrative MedicineFODMAP

Outcome Measures

Primary Outcomes (2)

  • IBS Symptom Severity Scale

    a validated tool which is currently the gold standard for evaluating interventions for IBS. Change in IBS Symptom Severity Scale at week 12 as compared to Baseline

    Baseline and week 12

  • IBS Quality of Life (IBS-QOL)

    Change in IBS-QOL at week 12 as compared to Baseline

    Baseline and Week 12

Secondary Outcomes (2)

  • Patient Global Impression of Change (PGIC)

    Baseline and Week 12

  • Perceived Stress Scale (PSS)

    Baseline and Week 12

Other Outcomes (1)

  • Center for Epidemiological Studies - Depression Scale (CES-D)

    Baseline and Week 12

Study Arms (2)

Nutrition/Mind-Body Coaching

OTHER

The intervention will consist of weekly group sessions lasting 75-90 minutes during which participants will receive training in the FODMAP diet and mind-body skills.

Behavioral: Nutrition/Mind-Body Coaching

Waitlist Control Group

NO INTERVENTION

Waitlist subjects. At the end of the 12-week study period, waitlist subjects will be offered the four-week nutrition and mind-body intervention.

Interventions

Following the four-week treatment intervention, participants will then be enrolled in an 8-week health coaching follow-up period. During this time participants will have a 45-60 minute telephone session with a health coach weekly for two weeks, then biweekly for four weeks.

Nutrition/Mind-Body Coaching

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • IBS diagnosis\> 12 months in duration
  • Over 18 years of age
  • English speaking

You may not qualify if:

  • Active major psychiatric illness which would potentially interfere with participation in the study 2. Pregnancy 3. Active eating disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Health and Healing

New York, New York, 10016, United States

Location

Related Publications (1)

  • Grundmann O, Yoon SL. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners. J Gastroenterol Hepatol. 2010 Apr;25(4):691-9. doi: 10.1111/j.1440-1746.2009.06120.x. Epub 2010 Jan 13.

    PMID: 20074154BACKGROUND

MeSH Terms

Conditions

Irritable Bowel Syndrome

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Elizabeth McDonald, MS,RD,CSS

    The Center for Health & HealingDepartment of Integrative MedicineMount Sinai Beth Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 28, 2015

First Posted

May 7, 2015

Study Start

April 1, 2015

Primary Completion

June 28, 2017

Study Completion

June 28, 2017

Last Updated

February 14, 2018

Record last verified: 2018-02

Locations